Using nanoparticles to improve imaging and treatment of ectopic pregnancy
Official title: Nanoparticle-mediated placental imaging and magnetic hyperthermia for management of ectopic pregnancy
Funded at Oregon State University · NIH-11059171 · Data updated 2026-11-12
This study is testing a new imaging method that uses tiny particles to help doctors better spot ectopic pregnancies, which happen when a fertilized egg grows outside the uterus, so that women can get the right treatment faster and more safely.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Oregon State University NIH-funded |
| Lab location | 1 site (Corvallis, United States) |
| Project start | June 1, 2023 |
| Project end | March 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $606,993 |
| NIH project number | 5R01HD112007-03 |
| Project ID | NIH-11059171 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are women who are in the early stages of pregnancy and are at risk for ectopic pregnancy.
✕Less likely to help
Patients who are not pregnant or those with confirmed intrauterine pregnancies will not benefit from this research.
What this research studies
This research focuses on developing a new imaging technique to better detect ectopic pregnancies, which occur when a fertilized egg implants outside the uterus, often in the fallopian tube. By utilizing nanoparticles that specifically target placental tissue, the study aims to enhance the accuracy of imaging methods like MRI, reducing the chances of misdiagnosis. The approach involves creating a biocompatible polymeric nanoplatform that can be injected into the bloodstream and will accumulate in the placenta without affecting the fetus. This could lead to more timely and effective treatments for ectopic pregnancies, potentially saving lives.
Why it matters
Potential benefit: If successful, this research could significantly improve the detection and management of ectopic pregnancies, reducing maternal mortality rates.
How similar studies have gone: Previous research has shown promise in using nanoparticles for targeted imaging, suggesting that this approach could be effective in improving ectopic pregnancy detection.
Where this research is happening
-
Oregon State University
Corvallis, United States Active
Researchers
- Principal investigator: Taratula, Olena — Oregon State University
- Study coordinator: Taratula, Olena
Related research
Other NIH-funded projects on the same topics.
-
How air pollution during pregnancy affects fetal growth over time
This study looks at how air pollution affects the growth of babies in the womb during pregnancy, using ultrasound images to track changes over time, and it aims to help expectant parents understand when their babies might be most at risk from pollution.
-
Postoperative Pain Guidelines for Pregnancy: Safer, Patient-Centered Opioid Use
We’re creating patient-friendly guidelines to help doctors manage pain after delivery and surgery in pregnant people, aiming to reduce opioid overuse and improve safety.
-
HPV and pregnancy risk: a big study following 1,280 pregnancies
A large pregnancy study at UTMB looks at whether human papillomavirus (HPV) during pregnancy is linked to problems like preterm birth.
-
Understanding how where you live and personal factors during pregnancy affect a child’s risk for obesity and metabolic problems
This project looks at how neighborhood conditions and individual factors during pregnancy may influence a child’s risk of obesity and metabolic health as they grow.
-
Blocking cancer-causing cMYC tricks after pregnancy changes in the breast
Researchers are testing how pregnancy and aging reshape the breast before cancer risk, using patient-reinformed models to see if it changes how dangerous cMYC signals behave.
-
SSRI use during pregnancy: effects on placental blood flow and inflammation
This grant studies how antidepressants (SSRIs) used during pregnancy might affect the placenta and inflammation, and whether a 5-HT2 receptor blocker could mitigate any negative effects.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.